Somerville Kurt F Sells 1,900 Shares of Roche Holding AG $RHHBY

Somerville Kurt F lowered its stake in Roche Holding AG (OTCMKTS:RHHBY) by 24.4% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,884 shares of the company’s stock after selling 1,900 shares during the period. Somerville Kurt F’s holdings in Roche were worth $240,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Rhumbline Advisers increased its holdings in shares of Roche by 7.4% during the first quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock valued at $4,413,000 after acquiring an additional 7,374 shares in the last quarter. Altrius Capital Management Inc grew its position in Roche by 3.6% during the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company’s stock valued at $7,818,000 after purchasing an additional 6,545 shares during the last quarter. Everett Harris & Co. CA bought a new stake in Roche during the 1st quarter valued at about $445,000. OLD National Bancorp IN raised its holdings in Roche by 2.9% in the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock worth $10,604,000 after buying an additional 7,326 shares during the last quarter. Finally, Bard Financial Services Inc. lifted its stake in shares of Roche by 25.3% in the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company’s stock worth $5,716,000 after buying an additional 28,050 shares in the last quarter.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Hsbc Global Res raised shares of Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 2nd. HSBC raised Roche from a “hold” rating to a “buy” rating and set a $50.00 target price for the company in a report on Thursday, October 2nd. Three equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Roche currently has an average rating of “Buy” and an average price target of $50.00.

Roche Stock Performance

Shares of RHHBY stock opened at $45.15 on Wednesday. The firm’s 50 day moving average is $40.95 and its 200 day moving average is $40.27. Roche Holding AG has a 12-month low of $34.10 and a 12-month high of $45.46.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.